home / stock / crmd / crmd quote
Last: | $11.35 |
---|---|
Change Percent: | -1.06% |
Open: | $11.4 |
Close: | $11.35 |
High: | $11.53 |
Low: | $11.25 |
Volume: | 1,039,256 |
Last Trade Date Time: | 07/09/2025 03:40:39 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$11.35 | $11.4 | $11.35 | $11.53 | $11.25 | 1,039,256 | 07-09-2025 |
$11.28 | $11.48 | $11.28 | $11.5 | $11.21 | 1,186,809 | 07-08-2025 |
$11.42 | $11.6201 | $11.42 | $11.74 | $11.35 | 1,607,442 | 07-07-2025 |
$11.62 | $11.63 | $11.62 | $11.73 | $11.34 | 1,079,245 | 07-04-2025 |
$11.62 | $11.63 | $11.62 | $11.73 | $11.34 | 1,079,245 | 07-03-2025 |
$11.59 | $11.76 | $11.59 | $11.855 | $11.445 | 1,985,904 | 07-02-2025 |
$11.79 | $12.23 | $11.79 | $12.265 | $11.72 | 2,932,429 | 07-01-2025 |
$12.32 | $12.635 | $12.32 | $12.65 | $12.15 | 3,016,005 | 06-30-2025 |
$12.5 | $12.86 | $12.5 | $12.98 | $12.14 | 9,896,096 | 06-27-2025 |
$14.96 | $15.05 | $14.96 | $15.13 | $14.57 | 1,330,025 | 06-26-2025 |
$14.97 | $15.56 | $14.97 | $15.6499 | $14.96 | 1,426,201 | 06-25-2025 |
$15.72 | $16.89 | $15.72 | $16.89 | $15.66 | 2,531,184 | 06-24-2025 |
$16.56 | $16.74 | $16.56 | $17.43 | $15.75 | 7,091,502 | 06-23-2025 |
$13.61 | $13.87 | $13.61 | $13.89 | $13.37 | 1,678,393 | 06-20-2025 |
$13.58 | $13.98 | $13.58 | $14.11 | $13.41 | 1,313,135 | 06-19-2025 |
$13.58 | $13.98 | $13.58 | $14.11 | $13.41 | 1,313,135 | 06-18-2025 |
$13.94 | $14.25 | $13.94 | $14.47 | $13.8801 | 1,135,064 | 06-17-2025 |
$14.34 | $14.76 | $14.34 | $14.77 | $14.18 | 927,122 | 06-16-2025 |
$14.56 | $14.62 | $14.56 | $14.99 | $14.54 | 1,184,192 | 06-13-2025 |
$14.86 | $14.45 | $14.86 | $14.91 | $13.83 | 1,267,556 | 06-12-2025 |
News, Short Squeeze, Breakout and More Instantly...
CorMedix Inc. Company Name:
CRMD Stock Symbol:
NASDAQ Market:
-1.06% G/L:
$11.35 Last:
1,039,256 Volume:
$11.40 Open:
$11.35 Close:
CorMedix Inc. Website:
BERKELEY HEIGHTS, N.J., June 27, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced the pricing of its previously announced underwritten pub...
BERKELEY HEIGHTS, N.J., June 26, 2025 (GLOBE NEWSWIRE) -- CorMedix Inc. (Nasdaq: CRMD), a biopharmaceutical company focused on developing and commercializing therapeutic products for life-threatening diseases and conditions, today announced that it intends to offer and sell $85.0 million of share...
2025-06-23 14:30:49 ET Compass Pathways Sinks 45% Despite Landmark Phase 3 Psilocybin Trial Results Compass Pathways plc ( CMPS ) plummeted 45.46% to lead losses in the PRISM Emerging Psychedelics Index even after announcing positive topline results from its Phase 3 COMP...